Cenpatico

cenpatico.com

Cenpatico’s expertise lies in managing benefits for vulnerable populations. Our healthcare specialties include behavioral health, foster care, school-based services, specialty therapy and rehabilitation and more. We have managed Medicaid and other public sector benefits since 1994; currently, we serve nearly 3 million members nationally. Our headquarters are in Austin, Texas and we have local teams across the country in the markets we serve. Cenpatico is a wholly-owned subsidiary of Centene Corporation. We are committed to innovative solutions and designing programs tailored to improving functional outcomes with our members.

Related News

NEW STANDARD LAUNCHED FOR ARTIFICIAL INTELLIGENCE IN HEALTHCARE

HITInfrastructure | March 03, 2020

news image

More than 50 organizations recently developed the first-ever ANSI-accredited standard for the use of artificial intelligence (AI) in healthcare. The organizations consist of major tech companies and healthcare industry leaders such as Amazon, AT&T, AMA, Fitbit, and Google, which were called on by the Consumer Technology Association (CTA). This standard will set a pathway for implementing medical and healthcare solutions build on AI. Standards are designed to serve the public through re...

Read More

FUTURE OF HEALTHCARE

OMNILIFE PARTNERS WITH REDOX TO ADD PATIENT REFERRAL MANAGEMENT TOOL TO ITS END-TO-END COMMUNICATION PLATFORM FOR TRANSPLANT HOSPITALS.

OmniLife | March 25, 2022

news image

OmniLife, a health technology communication and collaboration platform, has partnered with Redox, the industry-leading electronic health record integration and healthcare interoperability platform, to create a new integrated patient management tool as part of its overarching platform that provides end-to-end communication solutions for transplant hospitals. The new patient modules, OmniReferral and PatientStatus, will allow transplant centers to easily review new referrals and share...

Read More

FUTURE OF HEALTHCARE

EXO® ACQUIRES MEDO AI TO MAKE MEDICAL IMAGING AS EASY AS SNAPPING A SMARTPHONE PHOTO

Exo | July 27, 2022

news image

Exo a pioneering health information and medical devices company, announced that it is acquiring Medo, a Canadian developer of artificial intelligence (AI) technology, to make ultrasound imaging faster and simpler to use. By integrating Medo’s proprietary Sweep AI™ technology into its ultrasound platform, Exo will make ultrasound imaging more accessible to a wider range of caregivers. Ultrasound imaging is complex and requires specialized education and training. This limi...

Read More

ADDRESSING DISPARITIES WILL ADVANCE GENOMICS, PRECISION MEDICINE

HealthITAnalytics | January 27, 2020

news image

Advancements in genomics and precision medicine have improved healthcare’s understanding of human disease, but stakeholders will need to address disparities and increase data sharing in order to leverage the full potential of genomic medicine, according to a study published in Nature. Over the past two decades, technological advancements, as well as the collection and analysis of genetic and clinical data, have enhanced the use of genomics in healthcare. With these industry-wide changes, g...

Read More
news image

NEW STANDARD LAUNCHED FOR ARTIFICIAL INTELLIGENCE IN HEALTHCARE

HITInfrastructure | March 03, 2020

More than 50 organizations recently developed the first-ever ANSI-accredited standard for the use of artificial intelligence (AI) in healthcare. The organizations consist of major tech companies and healthcare industry leaders such as Amazon, AT&T, AMA, Fitbit, and Google, which were called on by the Consumer Technology Association (CTA). This standard will set a pathway for implementing medical and healthcare solutions build on AI. Standards are designed to serve the public through re...

Read More
news image

FUTURE OF HEALTHCARE

OMNILIFE PARTNERS WITH REDOX TO ADD PATIENT REFERRAL MANAGEMENT TOOL TO ITS END-TO-END COMMUNICATION PLATFORM FOR TRANSPLANT HOSPITALS.

OmniLife | March 25, 2022

OmniLife, a health technology communication and collaboration platform, has partnered with Redox, the industry-leading electronic health record integration and healthcare interoperability platform, to create a new integrated patient management tool as part of its overarching platform that provides end-to-end communication solutions for transplant hospitals. The new patient modules, OmniReferral and PatientStatus, will allow transplant centers to easily review new referrals and share...

Read More
news image

FUTURE OF HEALTHCARE

EXO® ACQUIRES MEDO AI TO MAKE MEDICAL IMAGING AS EASY AS SNAPPING A SMARTPHONE PHOTO

Exo | July 27, 2022

Exo a pioneering health information and medical devices company, announced that it is acquiring Medo, a Canadian developer of artificial intelligence (AI) technology, to make ultrasound imaging faster and simpler to use. By integrating Medo’s proprietary Sweep AI™ technology into its ultrasound platform, Exo will make ultrasound imaging more accessible to a wider range of caregivers. Ultrasound imaging is complex and requires specialized education and training. This limi...

Read More
news image

ADDRESSING DISPARITIES WILL ADVANCE GENOMICS, PRECISION MEDICINE

HealthITAnalytics | January 27, 2020

Advancements in genomics and precision medicine have improved healthcare’s understanding of human disease, but stakeholders will need to address disparities and increase data sharing in order to leverage the full potential of genomic medicine, according to a study published in Nature. Over the past two decades, technological advancements, as well as the collection and analysis of genetic and clinical data, have enhanced the use of genomics in healthcare. With these industry-wide changes, g...

Read More